Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Elrazi Awadelkarim A Ali"'
Autor:
Fateen Ata, Zohaib Yousaf, Adeel Ahmad Khan, Almurtada Razok, Jaweria Akram, Elrazi Awadelkarim Hamid Ali, Ahmed Abdalhadi, Diaeldin Abdelgalil Ibrahim, Dabia Hamad S. H. Al Mohanadi, Mohammed I. Danjuma
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Euglycemic diabetic ketoacidosis (EuDKA) secondary to Sodium-glucose co-transporter-2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported phenomenon. Not much is known about the burden of EuDKA in patien
Externí odkaz:
https://doaj.org/article/8c11be729c4a4190bbabeae68c63aca0
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 690-694 (2021)
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm (MPN) that harbors the Philadelphia chromosomal translocation resulting in the uncontrolled production of mature granulocytes. Commonly, patients are diagnosed with CML during blood work
Externí odkaz:
https://doaj.org/article/697abcf5042046a69ab1ac240479b0a6
Autor:
Elrazi Awadelkarim Hamid Ali, Ahmed Emad Mahfouz, Akhnuwkh Jones, Abdelatif Abdelmola, Mohamed A. Yassin
Publikováno v:
Case Reports in Gastroenterology, Vol 14, Iss 2, Pp 306-314 (2020)
Groove pancreatitis is an unusual form of pancreatitis characterized by fibrous inflammation and pseudo-tumor in the area around the head of the pancreas. The underlying etiology is unknown but is strongly linked to alcohol abuse. We report a 52-year
Externí odkaz:
https://doaj.org/article/54ee82a4bd0c4c9096ca8cdf47a74f5b
Autor:
Mohammad Abu-Tineh, Awni Alshurafa, Elrazi Awadelkarim Hamid Ali, Yousef Hailan, Waail Rozi, Abdulqader nashwan, mohamed yassin, Ashraf Omer Elamin Ahmed, Khalid Mohamed Ibrahim Alhaj ALbsheer
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S15- (2021)
Objective: Following the launch of the TKI's (tyrosine kinase inhibitors) for the treatment of CML, establishing its significant control over the disease, other dimensions have emerged in regard to the safety of treatment, particularly the effect on
Externí odkaz:
https://doaj.org/article/bbe76b12b82c4a159b160c08c959f90f
Autor:
Elrazi Awadelkarim Hamid Ali, Ibrahim Khamees, Awni Alshurafa, Hanaa Qasim, Mohammad Abdullah Abu-Tineh, Khaled Ahmed, Eltaib Saad, Mohamed Yassin
Publikováno v:
Oncology. 100:460-466
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral agent responsible for the coronavirus disease of 2019. The disease is primarily a respiratory illness; however, multisystem involvement is not uncommon. The infec
Eltrombopag is relatively new drug used in Thrombocytopenia. Its dose should be adjusted based on platelets count. It should be stopped when platelets count reach 400,000/mm³. Here, we share our case report of stopping Eltrombopag based on platelets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cae065766f2999c8a6466cda98e1afce
https://doi.org/10.22541/au.160438331.13299327/v1
https://doi.org/10.22541/au.160438331.13299327/v1
Autor:
Elabbass Abdelmahmuod, Mohamed Abdelrazek, Samah Kohla, Elrazi Awadelkarim A Ali, Mohamed A. Yassin, Mohanad A. Ahmed
Polycythemia vera (PV) characterize by an increase in RBCs and hemoglobin concentration. The typical presentation of PV is a plethora and thrombosis. Sites of thrombosis are Lower limbs. Rare sites of thrombosis are sagittal sinus. We report a case o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cce9e8c2032be3e322501b9b9d30e22
https://doi.org/10.22541/au.160310544.47999562/v1
https://doi.org/10.22541/au.160310544.47999562/v1
Autor:
Waail Rozi, Elrazi Awadelkarim Hamid Ali, Abdulrahman F. Al-Mashdali, Mohamed Abdelrazek, Mohamed A. Yassin
Publikováno v:
Medicine. 100:e27988
Autor:
Khalid Alhaj, Waail Rozi Kashgary, Abdulqadir J. Nashwan, Mohammad Abu-Tineh, Mohamed A. Yassin, Awni Alshurafa, Yousef Hailan, Elrazi Awadelkarim A Ali
Publikováno v:
Blood. 138:4613-4613
Introduction Following the launch of the TKI's (tyrosine kinase inhibitors) for the treatment of CML (Chronic myeloid leukemia), establishing its significant control over the disease as evident by multiple studies such as the population based Swedish
Autor:
Shehab F. Mohamed, Mohammed A Yasin, Elabbass Abdelmahmuod, Dina Sameh Soliman, Abdulqadir J. Nashwan, Elrazi Awadelkarim A Ali
Publikováno v:
Blood. 136:26-27
Introduction Acute leukemias can be divided into acute myeloid leukemia and acute lymphoblastic leukemia. Common presentations of acute leukemia include fever, symptoms of anemia, bleeding, bone pain palpable Lymph nodes or spleen and symptoms due in